Advisory Board

The Advisory Board at Chimeron Bio comprises experts in biotechnology and accessible medicines, providing strategic guidance on the company's research and development initiatives. They leverage their extensive knowledge to evaluate scientific progress, offer insights on market trends, and ensure that the development of saRNA-based therapeutics aligns with the needs of diverse patient populations. Their collective expertise helps steer the direction of novel RNA drugs and vaccines, fostering innovation and promoting ethical, accessible healthcare solutions.